NEW YORK, Oct. 3, 2022 /PRNewswire/ -- The "Anti-Thrombin III Testing Market by End-user (Hospitals, Laboratories, and Academic and research institutes) and Geography (North America, Europe, Asia, and Rest of World (ROW)) - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. North America will account for 38% of the market's growth during the forecast period. This growth is attributed to factors such as the growing adoption of anti-thrombin III testing for blood disorders in hospitals and laboratories. Moreover, market growth in this region will be faster than the growth of the market in other regions. The US and Canada are the key countries for the anti-thrombin III testing market in North America.
The potential growth difference for the anti-thrombin III testing market size between 2021 and 2026 is USD 161.48 million. To get the exact CAGR and the Y-O-Y growth rate, Request a FREE PDF Sample Report
- Market Driver: The existence of tests for patients with anti-thrombin deficiency is driving the growth of the market. The testing comprises various related tests, such as prothrombin time (PT) test, activated partial thromboplastin time (aPTT) test, and thrombin time (TT) test, which help detect blood clots. The presence of such tests will fuel the demand for anti-thrombin III testing products during the forecast period.
- Market Challenge: The lack of clinically available protocols to treat anti-thrombin deficiency is challenging the growth of the market. There is a lack of clinically available protocols to treat anti-thrombin deficiency, which may hinder the demand for anti-thrombin kits and reagents. Moreover, pregnant women with anti-thrombin deficiency are at a particularly high risk of developing clots during pregnancy or after delivery.
Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report
By end-user, the hospital segment will be the largest contributor to market growth during the forecast period. Hospitals use anti-thrombin III testing products such as reagents, assay kits, and systems to conduct diagnostic tests. The sales of these products are expected to increase in hospitals owing to the rise in patient admissions for surgeries and diagnoses. Many hospitals have their own laboratories to perform diagnostic tests and detect blood disorders. Moreover, organizations such as the Centers for Disease Control and Prevention (CDC) are taking initiatives such as the introduction of anti-thrombin III testing toolkits. This will increase the need for such products in hospitals.
View our FREE PDF Sample Report for additional insights into the contribution of all the segments and regional opportunities in the report
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Biron Health Group Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Invitae Corp.
- Merck KGaA
- Meridian Bioscience Inc.
- Oy Medix Biochemica Ab
- Randox Laboratories Ltd.
- Scripps Laboratories Inc.
- Sekisui Diagnostics LLC
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Transasia Bio Medicals Ltd.
- Werfenlife SA
Want your report customized? Speak to an analyst and personalize your report according to your needs
Related Reports
Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2022-2026: The point of care diagnostics market share is expected to increase by USD 13.09 billion from 2021 to 2026.
Molecular Microplate Readers and Washers Market by Product, End-user, and Geography - Forecast and Analysis 2022-2026: The molecular microplate readers and washers market share is expected to increase by USD 312.89 million from 2021 to 2026.
Anti-Thrombin III Testing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.73% |
Market growth 2022-2026 |
USD 161.48 million |
Market structure |
Fragmented |
YoY growth (%) |
5.3 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA |
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse Health Care Market Reports
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Hospitals - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
- 5.4 Laboratories - Market size and forecast 2021-2026
- Exhibit 32: Chart on Laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Laboratories - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Laboratories - Year-over-year growth 2021-2026 (%)
- 5.5 Academic and research institutes - Market size and forecast 2021-2026
- Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by End-user
- Exhibit 40: Market opportunity by End-user ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 89: Abbott Laboratories - Overview
- Exhibit 90: Abbott Laboratories - Business segments
- Exhibit 91: Abbott Laboratories - Key news
- Exhibit 92: Abbott Laboratories - Key offerings
- Exhibit 93: Abbott Laboratories - Segment focus
- 10.4 Becton Dickinson and Co.
- Exhibit 94: Becton Dickinson and Co. - Overview
- Exhibit 95: Becton Dickinson and Co. - Business segments
- Exhibit 96: Becton Dickinson and Co. - Key news
- Exhibit 97: Becton Dickinson and Co. - Key offerings
- Exhibit 98: Becton Dickinson and Co. - Segment focus
- 10.5 Bio Rad Laboratories Inc.
- Exhibit 99: Bio Rad Laboratories Inc. - Overview
- Exhibit 100: Bio Rad Laboratories Inc. - Business segments
- Exhibit 101: Bio Rad Laboratories Inc. - Key news
- Exhibit 102: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 103: Bio Rad Laboratories Inc. - Segment focus
- 10.6 Danaher Corp.
- Exhibit 104: Danaher Corp. - Overview
- Exhibit 105: Danaher Corp. - Business segments
- Exhibit 106: Danaher Corp. - Key news
- Exhibit 107: Danaher Corp. - Key offerings
- Exhibit 108: Danaher Corp. - Segment focus
- 10.7 F. Hoffmann La Roche Ltd.
- Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
- 10.8 Grifols SA
- Exhibit 114: Grifols SA - Overview
- Exhibit 115: Grifols SA - Business segments
- Exhibit 116: Grifols SA - Key offerings
- Exhibit 117: Grifols SA - Segment focus
- 10.9 Siemens AG
- Exhibit 118: Siemens AG - Overview
- Exhibit 119: Siemens AG - Business segments
- Exhibit 120: Siemens AG - Key news
- Exhibit 121: Siemens AG - Key offerings
- Exhibit 122: Siemens AG - Segment focus
- 10.10 Sysmex Corp.
- Exhibit 123: Sysmex Corp. - Overview
- Exhibit 124: Sysmex Corp. - Business segments
- Exhibit 125: Sysmex Corp. - Key offerings
- Exhibit 126: Sysmex Corp. - Segment focus
- 10.11 Thermo Fisher Scientific Inc.
- Exhibit 127: Thermo Fisher Scientific Inc. - Overview
- Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 129: Thermo Fisher Scientific Inc. - Key news
- Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
- 10.12 Transasia Bio Medicals Ltd.
- Exhibit 132: Transasia Bio Medicals Ltd. - Overview
- Exhibit 133: Transasia Bio Medicals Ltd. - Product / Service
- Exhibit 134: Transasia Bio Medicals Ltd. - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 135: Inclusions checklist
- Exhibit 136: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 137: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 138: Research methodology
- Exhibit 139: Validation techniques employed for market sizing
- Exhibit 140: Information sources
- 11.5 List of abbreviations
- Exhibit 141: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article